How long does lip filler last? An evidence-first answer.

Hyaluronic-acid (HA) lip filler typically lasts 6 to 18 months. The range is wide because "lasts" is not one thing — it is the overlap of three different curves: the visible cosmetic effect, the volume of crosslinked gel still present, and how much of either you, the patient, can detect in the mirror. The product matters. Technique matters more than the product. Anatomy and how mobile your lips are matter at least as much. And — this is where most consumer articles lie to you — gel that is "gone" from the volume curve is not always gone from the tissue. Recent magnetic-resonance imaging work suggests HA filler can remain detectable in facial tissue for years after the cosmetic effect has faded.

This article works through the mechanism, the brand-level data from FDA pivotal trials, the variables that bend the curve, and the part most patients are not told: how to tell "it wore off" apart from "it migrated."

The mechanism, briefly

Lip filler in the United States is almost exclusively crosslinked hyaluronic acid. HA is a glycosaminoglycan your body already makes; native HA has a half-life on the order of hours in skin. To turn that fragile molecule into something that stays in a lip for a year, manufacturers crosslink the chains with 1,4-butanediol diglycidyl ether (BDDE) or, in the Teoxane/RHA line, a "preserved network" process that uses lower crosslinking. The more crosslinking, the more resistant the gel is to the body's own hyaluronidases — which are the enzymes that degrade native HA and, eventually, the gel as well.

That is the entire game: how long the gel resists enzymatic and mechanical breakdown before the volume drops below what a patient or an injector can see.

Why "duration" depends on what you measure

There are three definitions, each giving a different number.

Cosmetic effect. Measured by validated scales like the Allergan Lip Fullness Scale. This is what FDA pivotal trials report, and the basis for "lasts up to one year" labeling.

Volume. Measured by 3D imaging or MRI. Declines faster than the cosmetic-effect curve, because some early apparent volume is post-injection edema, not gel.

Detectable presence. A 2024 MRI review of 33 mid-face patients found crosslinked HA still detectable on imaging from 2 to 15 years post-injection, with all 33 retaining filler at 2 years. The cosmetic effect was long gone in many of them. "Your filler is gone after a year" is not a literal statement about your tissue.

For the rest of this article, "lasts" means the cosmetic-effect curve, because that is what determines when you book a touch-up.

What the FDA pivotal trials actually showed

The lip-specific products approved by FDA each ran a sham- or delayed-treatment-controlled trial. The numbers below come from the manufacturer's Directions for Use and the FDA Summary of Safety and Effectiveness Data — primary sources, not marketing pages. Note that the trials use different definitions of "responder" and different endpoints, so the cross-product comparisons are imperfect.

Three honest observations.

First, "lasts up to one year" is the strongest claim any maker can support from a pivotal trial, and it needs footnotes. In the Juvéderm Ultra XC trial, the 1-year responder rate was 56% — meaning 44% of subjects no longer had a clinically meaningful improvement by 12 months. "Up to one year" is the ceiling, not the median.

Second, lower-HA-concentration, finer-particle products (Volbella, Kysse, RHA Redensity) are formulated for the lip body and perioral lines, where smooth integration matters more than lift. They look more natural in motion and last roughly comparable timeframes to firmer gels.

Third, the lip is not labeled-on for many products patients receive. Off-label use is legal and common; it is not by itself a safety issue, but the duration data you are quoted may come from a fold or cheek trial, not a lip trial.

Why duration varies by product

The chemistry that drives longevity is three knobs.

HA concentration. Volbella runs ~15 mg/mL; Vollure ~17.5 mg/mL; Voluma ~20 mg/mL. Concentration matters more for lift than for the calendar.

Crosslinking method. Juvéderm's Vycross blends high- and low-molecular-weight HA, which is why Vollure and Voluma outlast older Juvéderm Ultra. Restylane's NASHA yields firmer, particulate gels (Lyft, Refyne); their OBT line — Defyne, Refyne, Kysse — is smoother and more flexible. RHA uses lower crosslinking and a "preserved network" process intended to behave more naturally in dynamic tissue.

Rheology. G prime (G'), cohesivity, and tan delta describe how a gel deforms under force. High-G' gels (Voluma, Volux, Lyft, Defyne) resist deformation and lift; low-G' gels (Volbella, Kysse, Refyne) flow more and integrate better in mobile tissue. For lips you want low-to-mid G': the filler should move with the lip, not against it.

Translation: a stiff, heavily crosslinked gel in the static cheekbone may image-detectable for years. A softer gel in a mobile lip is metabolized faster — but looks better while it is there.

Anatomy: why lips burn through filler faster than cheeks

The mid-face MRI work documented HA detectable for 2 to 15 years in the cheek. No one is reporting equivalent persistence in lips. The reason is mechanical: lips move thousands of times a day. Every speaking, eating, or expressing cycle puts the gel under shear, which increases the surface area exposed to endogenous hyaluronidase and speeds enzymatic breakdown.

The vermillion has a rich vascular and lymphatic supply, so enzymes reach the gel quickly. The orbicularis oris is one of the most-used striated muscles in the body, and gel adjacent to it sits under near-constant mechanical load. This is why your filler from October is visibly gone by May while your friend's cheek filler from three years ago is still working.

What "metabolism" actually means

Patients hear that endurance athletes or people with "fast metabolism" lose filler faster. The published evidence is thin; the mechanistic story holds up.

Lip use. Singers, wind-instrument players, smokers, constant gum-chewers — all expose the gel to more shear and, mechanistically, burn through lip filler faster.

Aerobic exercise. Increased blood flow and heat may modestly accelerate gel turnover. The effect is real but smaller than patients fear. Skipping a workout the day of injection is about bruising, not durability weeks later.

Body mass and hormones. Not well-studied. No good evidence that thinner patients or specific hormone regimens metabolize filler dramatically faster.

Repeated treatment. Some studies suggest the duration of subsequent treatments in the same site is longer than the first, possibly because of scaffold persistence and tissue remodeling. Your second syringe may go further than your first.

Technique factors: where the injector matters more than the product

Two patients can receive the same syringe of the same filler on the same day and get six-month and eighteen-month results. The variable is technique.

Plane of injection. Filler placed in the deep submucosal plane of the lip — close to the muscle — tends to last longer than filler placed superficially. The trade-off is the look: deeper placement is structural; superficial placement is smooth and hydrated. Most modern lip techniques mix the two.

Total volume. A 1.0 mL syringe split across upper and lower lips will fade faster than 0.5 mL deposited in fewer, more strategic points. Volume is not duration. Over-injection accelerates apparent loss because the lip cannot hold what was placed.

Cannula vs. needle. Cannulas reduce bruising and vascular event risk; needles allow more precise micro-deposits. Duration data does not clearly favor one. Migration risk may be lower with cannulas in experienced hands.

Layering and product choice. A common modern approach is a structural gel (Vollure, RHA 3, Restylane Defyne) deep, and a softer gel (Volbella, Kysse, RHA Redensity) superficial. Single-product approaches are not wrong; they are a stylistic and economic choice.

Ask your injector which product, in which plane, at what total volume, and why. If the answer is "Juvéderm, the lip one" with no further specifics, you are paying a senior price for a junior service.

Expectations vs. reality: the honest fade curve

Here is what actually happens, in calendar order, with a typical 1.0 mL HA lip treatment by a competent injector.

Day 0 to 14. You look overdone. Most of what you see is edema, not gel. Do not judge the result yet. Do not get the touch-up yet.

Week 2 to 6. Settled appearance. This is the result you bought. Photograph yourself now; it is your baseline for comparison.

Month 3 to 6. Subtle softening. You will notice it; outside observers will not.

Month 6 to 9. Clear loss of definition, particularly in the vermillion border and Cupid's bow. Volume is still there; structure is fading.

Month 9 to 14. The "do I need a touch-up" window. By the FDA-pivotal definitions, more than half of patients still have a measurable improvement here. By the mirror test, most patients feel they are due.

Month 14 to 24. Below the cosmetic threshold for most patients. Gel may still be detectable on imaging.

If your filler appears to have "vanished" at month 4, the most likely explanations are: (1) the initial result was mostly swelling and the actual gel volume was modest; (2) the gel migrated rather than disappeared; or (3) you metabolize HA faster than average, which is real but rarer than patients think.

When "it's gone" actually means "it migrated"

This is the part most articles skip.

HA filler that appears to have lost volume in the lip body, with a simultaneous fullness or shelf above the upper lip ("filler mustache"), under the skin of the chin, or running along the philtral columns, has likely migrated rather than dissipated. Migration is well-documented in the peer-reviewed literature, and it is more common in the lip than in any other facial subsite.

The risk factors are knowable: total volume above what the lip anatomy can accommodate, superficial placement, repeated treatments without dissolving prior product, and certain injection techniques (vertical-needle deposits at the wet-dry border have been associated with hypervascularity and deeper deposition in recent ultrasound studies).

The diagnostic test is simple and underused: in-office ultrasound. A handheld 18 MHz probe can show where HA is sitting in seconds. If your lips look "deflated" but feel firm at the border, ask whether ultrasound is available before you book another syringe. Adding more on top of migrated filler does not fix the appearance; it makes it worse and is the proximate cause of most "overfilled" looks you see in public figures.

The hyaluronidase option

The fact that HA filler can be dissolved on demand is the single most important reason HA dominates the lip filler market over permanent or semi-permanent alternatives.

Hyaluronidase is an enzyme — most clinics use the ovine product Vitrase or the bovine product Hylenex — that hydrolyzes the glycosidic bond between glucosamine and glucuronic acid, breaking the HA polymer down into fragments the body clears within days. Injected into a lip, it does not distinguish between filler HA and your native HA; the native HA replenishes within roughly 24 hours.

Practical realities of dissolving:

• Dose. Rough rule of thumb in the literature: 5 to 15 units of hyaluronidase per 0.1 mL of HA filler, scaled to the crosslinking density of the specific product. Highly crosslinked gels (Voluma, Volux) need more enzyme than softer ones (Volbella, Kysse). A full 1 mL of lip filler is typically dissolved with 100 to 200 units.
• Timing. Visible reduction within 24 to 72 hours. Final result at 1 to 2 weeks.
• Specificity is poor. Hyaluronidase will dissolve native HA in adjacent tissue. The lips will look temporarily deflated and slightly aged for several days to a week before they rehydrate.
• Allergy is rare but real. A history of severe bee-venom allergy is a relative contraindication. Anaphylaxis to hyaluronidase has been reported.
• Migrated filler is the best indication. Dissolving entirely and starting over is almost always better than chasing a migrated result with more product.

If a clinic offers HA filler but cannot dissolve it on the same premises, choose a different clinic.

What to ask before booking

Skip "is this safe" — it is the wrong question and the answer is always "yes." Ask these instead.

1. Which exact product and lot, by syringe size, will you use? Get the brand and the variant — Juvéderm Volbella XC, not "Juvéderm."
2. Is that product FDA-approved for lip injection, or is this off-label?
3. What total volume, in mL, do you plan to place, and across how many sessions?
4. Cannula or needle, and where on the lip does each enter?
5. Do you have hyaluronidase on the premises today, and what is your protocol if I have a vascular event during the appointment?
6. Do you have ultrasound for assessing prior filler? If I have had filler before, will you scan before adding more?
7. What is your touch-up policy, and at what interval do you recommend the next syringe?

Two answers end the consultation: the injector cannot name the exact product, or hyaluronidase is not on site.

The honest summary

Hyaluronic-acid lip filler lasts 6 to 18 months as a cosmetic effect, with the median patient noticing meaningful fade between months 9 and 14. Product chemistry sets a range; injector technique sets where in the range you land; your anatomy and lip use shift that by months in either direction. Volume that appears to disappear early is often swelling that was never gel, or gel that migrated. The lip filler that has "lasted three years" without touch-ups is, more often than not, lip filler that migrated and is now sitting somewhere other than the lip body.

The right framework is not "how do I make it last longer." It is "what does the fade curve look like for my product, my technique, and my anatomy, and at what point on that curve do I want to retreat — or not."

Sources

• U.S. Food and Drug Administration. Dermal Filler Do's and Don'ts for Wrinkles, Lips and More. https://www.fda.gov/consumers/consumer-updates/dermal-filler-dos-and-donts-wrinkles-lips-and-more
• U.S. Food and Drug Administration. JUVÉDERM® VOLBELLA® XC – P110033/S053 (approval page). https://www.fda.gov/medical-devices/recently-approved-devices/juvedermr-volbellar-xc-p110033-s053
• U.S. Food and Drug Administration. RHA 3 Dermal Filler – P170002/S030 (approval page). https://www.fda.gov/medical-devices/recently-approved-devices/rha-3-dermal-filler-p170002s030
• FDA / CDRH. Directions for Use, JUVÉDERM® VOLBELLA® XC (P110033/S053). https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110033S053C.pdf
• FDA / CDRH. Directions for Use, JUVÉDERM® Ultra XC (P050047/S044). https://www.accessdata.fda.gov/cdrh_docs/pdf5/P050047S044d.pdf
• FDA / CDRH. About JUVÉDERM® Ultra XC for Lip Augmentation. https://www.accessdata.fda.gov/cdrh_docs/pdf5/p050047s044c.pdf
• FDA / CDRH. Summary of Safety and Effectiveness Data, Restylane® Kysse (P140029/S021). https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140029S021B.pdf
• FDA / CDRH. Directions for Use, Restylane® Kysse (P140029/S021). https://www.accessdata.fda.gov/cdrh_docs/pdf14/P140029S021C.pdf
• American Academy of Dermatology. Fillers: FAQs. https://www.aad.org/public/cosmetic/wrinkles/fillers-faqs
• American Academy of Dermatology. Fillers: Overview. https://www.aad.org/public/cosmetic/wrinkles/fillers-overview
• American Society for Dermatologic Surgery. Dermal Fillers. https://www.asds.net/skin-experts/skin-treatments/dermal-fillers
• American Society for Dermatologic Surgery. Preventing and Treating Adverse Events of Injectable Fillers — Evidence-Based Recommendations from the ASDS Task Force. https://www.asds.net/Portals/0/PDF/asdsa/Preventing%20and%20Treating%20Adverse%20Events%20of%20Injectable%20Fillers%20Evidence-Based%20Recs%20From%20ASDS%20Task%20Force%20Article.pdf
• Schelke L, et al. Hyaluronic Acid Filler Longevity in the Mid-face: A Review of 33 Magnetic Resonance Imaging Studies. PubMed (2024). https://pubmed.ncbi.nlm.nih.gov/39015357/
• Efficacy and Safety of Hyaluronic Acid Lip Fillers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PubMed (2025). https://pubmed.ncbi.nlm.nih.gov/41186199/
• Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10836581/
• Fundamental considerations for the use of hyaluronidase, an enzyme for degrading HA fillers. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11217013/
• Filler Migration: A Number of Mechanisms to Consider. PubMed. https://pubmed.ncbi.nlm.nih.gov/25650796/
• Ultrasound Evaluation of Lip Anatomy and Filler Placement: A Cross-Sectional Study of Injection Accuracy, Migration, and Demographic Variation. PubMed. https://pubmed.ncbi.nlm.nih.gov/41494527/
• Exploring facial overfilled syndrome from the perspective of anatomy and the mismatched delivery of fillers. PubMed. https://pubmed.ncbi.nlm.nih.gov/38369859/